全文获取类型
收费全文 | 54511篇 |
免费 | 4678篇 |
国内免费 | 1860篇 |
出版年
2023年 | 383篇 |
2022年 | 953篇 |
2021年 | 1884篇 |
2020年 | 1161篇 |
2019年 | 1455篇 |
2018年 | 1478篇 |
2017年 | 1067篇 |
2016年 | 1699篇 |
2015年 | 2684篇 |
2014年 | 3096篇 |
2013年 | 3459篇 |
2012年 | 4267篇 |
2011年 | 4012篇 |
2010年 | 2469篇 |
2009年 | 2088篇 |
2008年 | 2614篇 |
2007年 | 2570篇 |
2006年 | 2330篇 |
2005年 | 2107篇 |
2004年 | 1973篇 |
2003年 | 1793篇 |
2002年 | 1653篇 |
2001年 | 888篇 |
2000年 | 827篇 |
1999年 | 866篇 |
1998年 | 651篇 |
1997年 | 525篇 |
1996年 | 531篇 |
1995年 | 535篇 |
1994年 | 507篇 |
1993年 | 383篇 |
1992年 | 519篇 |
1991年 | 417篇 |
1990年 | 444篇 |
1989年 | 386篇 |
1988年 | 328篇 |
1987年 | 309篇 |
1986年 | 290篇 |
1985年 | 293篇 |
1984年 | 301篇 |
1983年 | 244篇 |
1982年 | 291篇 |
1981年 | 285篇 |
1980年 | 268篇 |
1979年 | 217篇 |
1978年 | 204篇 |
1977年 | 186篇 |
1976年 | 203篇 |
1974年 | 184篇 |
1973年 | 204篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
31.
Charles Romeo Naoko Moriwaki Kerry T. Yasunobu Irwin C. Gunsalus Hideo Koga 《Journal of Protein Chemistry》1987,6(3):253-261
The first 12 NH2-terminal amino acids of the Pseudomonas putida putidaredoxin reductase were shown to be Met-Asn-Ala-Asn-Asp-Asn-Val-Val-Ile-Val-Gly-Thr. Comparison of these data with the DNA sequence of the BamHI-HindIII 197-base fragment derived from the PstI 2.2-kb fragment obtained from the P. putida plasmid showed that the putidaredoxin reductase gene was downstream from the cytochrome P-450 gene and the intergenic region had the 24-nucleotide sequence TAAACACATGGGAGTGCGTGCTAA. The Shine-Dalgarno sequence GGAG was detected in this region. The initiating triplet for the reductase gene was GTG, which normally codes for valine, but in the initiating codon position codes for methionine. From the amino acid sequence and X-ray data comparisons with other flavoproteins, what appears to be the AMP binding region of the FAD can be recognized in the NH2-terminal portion of the reductase involving residues 5–35.This article was presented during the proceedings of the International Conference on Macromolecular Structure and Function, held at the National Defence Medical College, Tokorozawa, Japan, December 1985. 相似文献
32.
Charles B. Lindemann 《Biophysical journal》2009,97(11):2865-2866
33.
34.
35.
36.
Chen Chen Raymond Dagnino Jr. Charles Q. Huang James R. McCarthy Dimitri E. Grigoriadis 《Bioorganic & medicinal chemistry letters》2001,11(24):3165-3168
Cyclizations of alkylhydrazines with N-acyl-S-methylisothioureas, readily synthesized from acyl chlorides, sodium thioisocyanate, dialkylamines then methyl iodide in a one-pot reaction, gave 1-alkyl-3-dialkylamino-5-phenyltriazoles 7 as major products. The regioisomers were assigned through the use of NOE NMR experiments. While bearing a N-bis(cyclopropyl)methyl-N-propylamino group, this series of compounds shows very good binding affinity on the human CRF1 receptor. Among them, 1-methyl-3-[N-bis(cyclopropyl)methyl-N-propylamino]-5-(2,4-dichlorophenyl)-1H-[1,2,4]triazole 7a had the best binding affinity for the CRF1 receptor (Ki=9 nM). 相似文献
37.
38.
39.
Jian Xiao Dan Chen Xiu-Xian Lin Shi-Fang Peng Mei-Fang Xiao Wei-Hua Huang Yi-Cheng Wang Jing-Bo Peng Wei Zhang Dong-Sheng Ouyang Yao Chen 《PloS one》2016,11(2)
Ginsenoside compound K (CK), a rare ginsenoside originating from Panax Ginseng, has been found to possess unique pharmacological activities specifically as anti-cancers. However, the role of cytochrome P450s (CYPs) in the metabolism of CK is unclear. In this study, we screened the CYPs for the metabolism of CK in vitro using human liver microsomes (HLMs) or human recombinant CYPs. The results showed that CK inhibited the enzyme activities of CYP2C9 and CYP3A4 in the HLMs. The Km and Vmax values of CK were 84.20±21.92 μM and 0.28±0.04 nmol/mg protein/min, respectively, for the HLMs; 34.63±10.48 μM and 0.45±0.05 nmol/nmol P450/min, respectively, for CYP2C9; and 27.03±5.04 μM and 0.68±0.04 nmol/nmol P450/min, respectively, for CYP3A4. The IC50 values were 16.00 μM and 9.83 μM, and Ki values were 14.92 μM and 11.42μM for CYP2C9 and CYP3A4, respectively. Other human CYP isoforms, including CYP1A2, CYP2A6, CYP2D6, CYP2E1, and CYP2C19, showed minimal or no effect on CK metabolism. The results suggested that CK was a substrate and also inhibitors for both CYP2C9 and CYP3A4. Patients using CK in combination with therapeutic drugs that are substrates of CYP2C9 and CYP3A4 for different reasons should be careful, although the inhibiting potency of CK is much poorer than that of enzyme-specific inhibitors. 相似文献
40.